97103 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Sub-classes:NON-HUMAN ANIMALS HAVING MODIFIED IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION LOCUS AND USES THEREOF
#2Anti-Inflammatory Polypeptides
#3Nasally Administered Formulations for Reducing Allergic Symptoms and Methods of Using the Same
#4MONOCLONAL ANTIBODIES AGAINST JC VIRUS
#5METHODS AND COMPOSITIONS OF VIRUS-LIKE PARTICLES OF CYTOPLASMIC TYPE CITRUS LEPROSIS VIRUS FOR NANOTECHNOLOGY APPLICATIONS
#6ANTIBODIES WITH NOVEL FC MODIFICATION COMBINATIONS THAT INCREASE ANTIBODY FUNCTION
#7IGG1 FC MONOMER AND APPLICATION THEREOF
#8Chimeric Natural Killer Cell Receptors and Method of Using Thereof
#9FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS
#10MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE
#11METHODS OF IMMUNOTHERAPY
#12VIRAL VECTOR-DERIVED TARGET PROTEIN FOR ANTICANCER THERAPY AND BINDING MOLECULE OR FRAGMENT THEREOF SPECIFICALLY BINDING THERETO
#13Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
#14COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY
#15Covalent Diabodies and Uses Thereof
#16PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS
#17CELLS AND METHODS OF USES AND MAKING THE SAME
#18Anti-Inflammatory Polypeptides
#19METHOD FOR ALTERING PLASMA RETENTION AND IMMUNOGENICITY OF ANTIGEN-BINDING MOLECULE
#20COMPOSITIONS AND METHODS FOR PRODUCING HUMAN POLYCLONAL ANTIBODIES
#21MASK PEPTIDES AND MASKED ANTI-PTK7 ANTIBODIES COMPRISING SUCH
#22Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
#23Compositions and methods for the treatment of immunodeficiency
#24MONOCLONAL ANTIBODIES AGAINST JC VIRUS
#25North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#26ANTIBODIES
#27ACE2- and TMPRSS2-Targeted Compositions and Methods for Treating COVID-19
#28Fc Receptor-ACE2 Conjugates and Use Thereof
#29IMMUNOGENIC COMPOSITION
#30Adeno-associated virus antibodies, fragments thereof and encoding polynucleotides
#31MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND MULTI-ANTIBODY THERAPEUTICS
#32ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF
#33Method of treating, reducing, or alleviating a medical condition in a patient
#34IgG1 FC monomer and application thereof
#35Anti-inflammatory polypeptides
#36Compositions and methods for the treatment of immunodeficiency
#37Anti-inflammatory polypeptides
#38Monoclonal antibody and vaccine targeting filamentous bacteriophage
#39COMPOSITIONS AND METHODS FOR INHIBITION OF ALPHAVIRUS INFECTION
#40Chimeric Natural Killer Cell Receptors and Method of Using Thereof
#41Binding molecules directed against influenza hemagglutinin and uses thereof
#42Killer cell capable of efficiently and stably expressing antibody, and uses thereof
#43Formulations of antibody molecules to dengue virus
#44Method for altering plasma retention and immunogenicity of antigen-binding molecule
#45North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#46SIMULTANEOUS IN VITRO ANALYSIS OF VACCINE POTENCY AND TOXIN CONCENTRATION
#47Cells and Methods of Uses and Making the Same
#48Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
#49Monoclonal antibody and vaccine targeting filamentous bacteriophage
#50Compositions, methods and kits to detect herpes simplex virus nucleic acids
#51Method for the Virus Inactivation of a Preparation of Monoclonal Antibodies
#52Binding molecules directed against influenza hemagglutinin and uses thereof
#53CHIMERIC ANTIBODIES COMPRISING BINDING DOMAINS OF PHAGE LYSINS, BACTERIAL AUTOLYSINS, BACTERIOCINS, AND PHAGE TAIL OR TAIL FIBERS
#54Fc mutants with improved functional activity
#55Use of immobilization particles for removal of microorganisms and/or chemicals
#56Immunogenic composition
#57IMMUNOCHROMATOGRAPHY ANALYSIS DEVICE FOR DETECTING ZIKA VIRUS
#58Covalent Diabodies and Uses Thereof
#59High avidity HPV T-cell receptors
#60Multivalent FV antibodies
#61Compositions and Methods for Evaluating Viral Receptor/Co-Receptor Usage and Inhibitors of Virus Entry Using Recombinant Virus Assays
#62Compositions, methods and kits to detect Herpes Simplex virus nucleic acids
#63HIGHLY EXPRESSED PROTECTIVE PLANT-DERIVED BROADLY NEUTRALIZING HIV MONOCLONAL ANTIBODIES FOR USE IN PASSIVE IMMUNOTHERAPY
#64Compositions and methods for the treatment of immunodeficiency
#65Methods and compositions for eliciting an immune response against hepatitis B virus
#66Method for the reduction of viral titer in pharmaceuticals
#67Antibody dual display dual compositions and methods of use thereof
#68Compositions and methods for the treatment of immunodeficiency
#69Device and method for detecting a target analyte
#70Binding molecules directed against influenza hemagglutinin and uses thereof
#71Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus
#72Modified Sendai virus vaccine and imaging vector
#73Compositions, methods and kits to detect herpes simplex virus nucleic acids
#74Method for purification of monoclonal antibodies
#75Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
#76High affinity human antibodies to human cytomegalovirus (CMV) gB protein
#77Method for neutralizing hepatitis C virus, fully human monoclonal antibody against hepatitis C virus (variants), composition of fully human monoclonal antibodies against hepatitis C virus and hybrid mouse/human producer cell line of fully human monoclonal antibodies against hepatitis C virus (variants)
#78Prophylactic vaccine against egg drop syndrome (EDS)
#79MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE
#80Synthetic antiserum for rapid-turnaround therapies
#81Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
#82Covalent diabodies and uses thereof
#83Synbodies for detection of human norovirus
#84Use of immobilization particles for removal of microorganisms and/or chemicals
#85Compositions and methods for the treatment of immunodeficiency
#86Compositions and methods for the treatment of immunodeficiency
#87METHODS AND KITS FOR THE DETECTION OF VIRAL INFECTIONS
#88High affinity human antibodies to human cytomegalovirus (CMV) GB protein
#89BIOMARKER DETECTING PROBE CAPABLE OF EARLY DETECTION AND PRECISE QUANTIFICATION AND USE THEREOF
#90Non-sialylated anti-inflammatory polypeptides
#91ALPHABODIES SPECIFICALLY BINDING TO VIRAL PROTEINS AND METHODS FOR PRODUCING THE SAME
#92Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
#93Modified Sendai virus vaccine and imaging vector
#94Expression cassette for efficient surface display of antigenic proteins
#95Method for altering plasma retention and immunogenicity of antigen-binding molecule
#96Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
#97North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#98Methods of enhancing antibody-based antiviral therapies by administering KIR2DL-binding antibodies
#99Newcastle disease virus and the use thereof as a vaccine
#100LIPID-CONJUGATED ANTIBODIES
#101MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINS
#102METHODS AND COMPOSITIONS RELATED TO INTRACELLULAR NEUTRALIZATION BY IgG
#103Method for in-vivo binding of chromatin fragments
#104Methods and compositions for eliciting an immune response against hepatitis B virus
#105Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases
#106Immobilization Particles for Removal of Microorganisms and/or Chemicals
#107High affinity human antibodies to human cytomegalovirus (CMV) gB protein
#108MN gene and protein
#109System for selective cell treatment using ideotypically modulated pharmacoeffectors
#110NUCLEIC ACID OCCURRING IN BLOOD FROM HEPATITIS PATIENT, POLYPEPTIDE ENCODED BY THE NUCLEIC ACID, AND USES OF THE SAME
#111METHOD FOR TARGETED AND SUSTAINED ANTIVIRAL THERAPY
#112IMMUNOGEN SELECTION DIRECTED IN IMMUNOGLOBULIN PACKAGES IN PLASMA AND COLOSTRUM AND METHOD OF MAKING AND USING SAME
#113Methods for isolation of antibody binding to cells
#114Methods for determining the presence of antibodies blocking viral infection
#115MN gene and protein
#116MN Gene and Protein
#117Selection of intracellular immunoglobulins
#118Compositions and methods for detection of antibody binding to cells
#119MN Gene and Protein
#120Methods of treating viral infections by administering KIR2DL-binding antibodies
#121Immunoglobin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
#122Methods of Making Passive Immunotherapies
#123MN Gene and Protein
#124Polyclonal antibody product
#125MN Gene and Protein
#126Modified plant viruses and methods of use thereof
#127Monoclonal Antibody 3F1H10 Neutralising VHSV (Viral Haemorrhagic Septicaemia Virus)
#128MN gene and protein
#129Covalent diabodies and uses thereof
#130MN gene and protein
#131Pharmaceutical compositions and articles of manufacture useful in reversal of a clinical epiosode of an incurable disease and methods of use thereof
#132Compositions and methods for detection of antibody binding to cells
#133Prevention and treatment of the porcine reproductive and respiratory syndrome (PRRS)
#134Rh(D)-binding proteins
#135Methods and compound protein molecules used for inducing cytotoxic cell-mediated immune response in a mammal against a pathogenic cell
#136Heteropolymer complexes and methods for their use
#137Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
#138Compositions and methods for the modulation of viral maturation
#139Immunoglobulin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
#140MN gene and protein